Phase 2 multi-center study of tazemetostat (EPZ-6438), an inhibitor of enhancer of zeste-homolog 2 (EZH2), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)

Franck Morschhauser; Gilles A. Salles; Steven Le Gouill; John A. Radford; Pamela McKay; Guillaume Cartron; Patricia J. Pimentel; Maria Roche; Stephen J Blakemore; Alice McDonald; Natalie Warholic; Shelley Knight; Peter T.C. Ho; Vincent Ribrag

doi:10.1200/JCO.2016.34.15_suppl.TPS7582

$Phase 2 multi-center study of tazemetostat (EPZ-6438), an inhibitor of enhancer of zeste-homolog 2 (EZH2), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)$

Article de revue

Avec comité de lecture

Phase 2 multi-center study of tazemetostat (EPZ-6438), an inhibitor of enhancer of zeste-homolog 2 (EZH2), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)

Franck Morschhauser, Gilles A. Salles, Steven Le Gouill, John A. Radford, Pamela McKay, Guillaume Cartron, Patricia J. Pimentel, Maria Roche, Stephen J Blakemore, Alice McDonald, …

Journal of clinical oncology, Vol.34(15_suppl), pp.TPS7582-TPS7582

20/05/2016

DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.TPS7582

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: Phase 2 multi-center study of tazemetostat (EPZ-6438), an inhibitor of enhancer of zeste-homolog 2 (EZH2), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)
Créateurs - sans rôle: Franck Morschhauser - Hôpital Claude Huriez
Gilles A. Salles - University De Lyon, Hospices Civils De Lyon, Lyon, France
Steven Le Gouill - University Hospital Nantes, Nantes, France
John A. Radford - The Christie NHS Foundation Trust
Pamela McKay - Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Guillaume Cartron - University Hospital Montpellier, Montpellier, France
Patricia J. Pimentel - Epizyme, Cambridge, MA
Maria Roche - Epizyme, Cambridge, MA
Stephen J Blakemore - Epizyme, Cambridge, MA
Alice McDonald - Epizyme, Cambridge, MA
Natalie Warholic - Epizyme, Cambridge, MA
Shelley Knight - Epizyme, Cambridge, MA
Peter T.C. Ho - Epizyme, Cambridge, MA
Vincent Ribrag - Institut Goustave Roussy, Villejuif, France
Détails de publication: Journal of clinical oncology, Vol.34(15_suppl), pp.TPS7582-TPS7582
Identifiants: 99139776709311
Unité académique: Institut de Génétique Moléculaire de Montpellier - IGMM
Langue: English
Type de ressource: Journal article